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Calculating Excess Lifetime Risk in Relative
Risk Models
by Michael Vaeth* and Donald A. Piercet
When assessing the impact ofradiation exposure it is common practice to present the final conclusions
in terms of excess lifetime cancer risk in a population exposed to a given dose. The present investigation
is mainly a methodological study focusing on some of the major issues and uncertainties involved in
calculating such excess lifetime risks and related risk projection methods. The age-constant relative risk
model used in the recent analyses ofthe cancer mortality that was observed in the follow-up ofthe cohort
ofA-bomb survivors in Hiroshima andNagasaki is used todescribe the effect ofthe exposure onthe cancer
mortality. In this type ofmodel the excess relative risk is constant in age-at-risk, but depends on the age-
at-exposure. Calculation of excess lifetime risks usually requires rather complicated life-table computa-
tions. In this paper we propose a simple approximation to the excess lifetime risk; the validity of the
approximation forlowlevelsofexposureisjustifiedempiricallyaswellastheoretically. Thisapproximation
provides important guidance in understanding the influence of the various factors involved in risk pro-
jections. Among the further topics considered are the influence ofa latent period, the additional problems
involved in calculations of site-specific excess lifetime cancer risks, the consequences of a leveling off or
a plateau in the excess relative risk, and the uncertainties involved in transferring results from one
population to another. The main part of this study relates to the situation with a single, instantaneous
exposure, but a brief discussion is also given of the problem with a continuous exposure at a low-dose
rate.
Introduction
The motivation forthe presentinvestigation has been
the analysis by the Radiation Effects Research Foun-
dation (RERF) of the cancer mortality of the A-bomb
survivors in Hiroshima and Nagasaki (1-3); this is, to
some extent, reflected in the issues selected for discus-
sion here. However, calculation of excess lifetime risk
and related risk projection methods are also relevant
when evaluating the impact of exposure to various en-
vironmental and occupational hazards (4,5), and it is
believed that some ofthe resultsgivenheremight prove
useful in this broader setting.
Analyses ofthe follow-up ofthe A-bomb survivors in
the Life Span Study (LSS) cohort have shown that for
most cancer sites the excess mortality rates have con-
tinued to increase until the presenttime. Moreover, this
increase is modeled remarkably well by age-constant
relative risk models over the current follow-up period
(1-3). It should be emphasized that the term "age-con-
stant relative risk" here refers to constancy in age-at-
risk rather than age-at-exposure. The type of models
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that describe the data will involve excess relative risks
thatare, foragivenage-at-exposure, constantinregard
to age-at-risk over the follow-up but they decrease sub-
stantially with age-at-exposure. For all cancers except
leukemia, which is considered as one group, these ex-
cess relative risks also depend markedly onthe sex, but
to a large extent this sex dependence simply offsets the
sex ratio in the background cancer rates.
When presenting results on the excess cancer mor-
tality in this cohort, it has been common practice to
express the ultimate conclusions in terms ofexcess life-
time cancer risks, also denoted the lifetime cancer risk
from exposure (3,6-10). Note however, that in most of
these references a different measure of excess risk
called here "the riskofuntimelycancerdeath" was com-
puted, but the name "excess lifetime risk" was used (C.
Land, private communication).
As a measure of excess cancer deaths, the excess
lifetime risk has several drawbacks largely related to
the fact that since everybody must die, excess cancer
mortality can only occur by decreasing the mortality to
other causes; this has important implications for cal-
culation ofsite-specific excess lifetime risks afterwhole-
body exposure. In particular, ifit had been found that
radiation increases the rate ofall major causes ofdeath
by the same factor, then there would be no excess life-
time cancerriskatall(but, ofcourse, thelifeexpectancy
would be shortened). Some of these complications are
discussed in this paper. Although it might be an ad-VAETH AND PIERCE
vantage to put more emphasis on presenting the final
conclusionsinterms ofage-specificexcessrelativerisks,
considerations of lifetime risks are important, even if
only to put current results in the perspective of what
has been given in the past.
Computation ofexcess lifetime cancerrisks is usually
basedonrathercomplicated life-table calculations. Such
detailed calculations are certainly important, but they
are not very helpful in understanding the relative im-
portance of the different factors entering the calcula-
tions. In this paper some simple approximate expres-
sionsarederivedandevaluatedbycomparingthemwith
the detailed life-table calculations. The approximate
expressions highlight the important issues involved in
excess lifetimeriskcalculations forrelative riskmodels.
Three aspects ofthe excess mortality are clearly im-
portant in any risk projection, namely the length ofthe
latent period, the magnitude ofthe effect, and the du-
ration of the effect. The first two of these are incor-
porated in the general developments. For the duration
aspect most ofthe results given presume a lifelong ex-
cess relative risk, but deviations from this pattern are
also considered.
Briefly, the organization ofthe paper is as follows: In
the next section the terminology is introduced and the
basic competing risks model is described. An explicit
relation for the excess lifetime cancer risk is derived in
the section entitled "Results Based on Assuming Pro-
portional Mortality Rates." Thisrelationis based onthe
assumption that the age-specific mortality rates for all
causes and for cancer are proportional in age. Using
Japanese life-tables for 1965 and 1985 and nonleukemia
cancer risk associated with acute radiation exposure,
the general validity of this expression is investigated
by comparing the results with those based on the de-
tailed life-table calculations. The section "Approxima-
tionunderWeakerAssumptions" contains some further
theoretical developments. In the general setting,
bounds for the excess lifetime risks are given, showing
that for low-exposure levels the simple approximation
isexpectedtoperformwellinawiderangeofsituations.
The proof of these results is sketched in Appendix C.
The additional problems that occurwhenmore than one
cause ofdeath is related to the exposure are addressed
in the section dealing with exposure-related causes of
death. Finally, the section "Some Further Issues" tries
to cover some other major issues and uncertainties in-
volved in lifetime risks calculations such as the impor-
tance of age at exposure, the implications of a plateau
inthe excessrelativerisk, andtransferringresultsfrom
one population to another.
The main part ofthe results relate to a situation with
a single, instantaneous exposure. This is partly because
the present paper grew out ofour work on the analysis
of the follow-up of the A-bomb survivors but also be-
cause the mathematics are simpler for this type of ex-
posure. However, in the sixth section the problem with
continuous exposure at a low-dose rate is briefly ad-
dressedandasimpleapproximaterelationfortheexcess
lifetime risk is suggested.
The Competing Risks Model
Thebasicmodelused hereis acompetingrisksmodel,
ormultiple decrementmodel, withtwo causesofdeaths,
cancerand noncancer(11,12). Cancer as a causeofdeath
is assumed to be related to the level of exposure,
whereas the noncancer mortality is assumed to be in-
dependent of the exposure. These assumptions mirror
thefindings inthe LSS cohortwhere aradiation-related
excess mortality is found for most cancer sites, but no
excess mortality has been established forthe other ma-
jor causes of death (13,14).
Let us first develop the basic relations for the unex-
posed (background) population. The cause-specific mor-
tality rates in the unexposed population as a function
of age, a, are denoted by mj(a) for cancer and mn(a)
for noncancer. The total mortality rate at age a is then
m(a) = mj(a) + mn(a)
These rates will in general also depend on the sex and
to some extent on the birth cohort and the calendar
period, buttoavoid acomplexnotation, thisdependence
is ignored here. The main results are not affected by
this simplification. Itis also convenient to introduce the
corresponding integrated mortality rates mj(a), m-(a)
and m(a) where, e.g.,
ra
MX(a) = ) dx
and M,a) and M(a) are defined in a similar way.
The survivor function gives the probability of being
alive as a function ofthe age a. This probability can be
expressed as
S(a) = exp{-M(a)}.
In particular, S(O) = 1. The conditional probability of
being alive at age y, given alive at age x, is denoted by
S(y:x) and is obtained as
S(y:X) = S(y)/S(x) = exp{-[M(y) - M(x)]}.
This survivor function gives the proportion still alive at
age y among those alive at age x.
The lifetime cancer risk for someone alive at age x,
B(x), can now be obtained as the integral ofthe product
of the survivor function and the cancer mortality rate
over all ages y greater than x, i.e.,
B(x) = 7m(y)S(y:x) dy (1)
The lifetime risk B(x) is the proportion of all eventual
deaths among those alive at age x, which are due to
(background) cancer. The calculations needed to derive
the lifetime risk from a particular life-table are briefly
reviewed in Appendix A.
Next, the impact of exposure on a population of in-
dividuals exposed at age e or a population with a given
age distribution is considered. By assumption the non-
cancer mortality rate is unchanged. Let m (a:e) and
m'(a:e) denote the cancer mortality rate and the total
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mortality rate at age a for someone exposed at age e.
Also, for the other measures to be considered, a prime
will be used to indicate that the particular function re-
ferstothe exposedpopulation. Ingeneralm (a:e)might
be a rather complicated function of the dose received,
the age, the age at exposure, the time since exposure,
and the background cancer mortality rate mj(a). The
statisticalmethodsforestimatingthisrelationshipisnot
the issue here. When calculating excess lifetime risks,
one willnormally considertheimplications ofaspecified
dose to anindividual orapopulation ofindividuals. This
will also be the approach taken here. Thus, theproblem
to be considered involves a comparison of the cancer
risks in two populations, an unexposed and an exposed.
The individuals in the latter population all receive the
same dose and the excess lifetime risk to be computed
is only relevant for this exposure level.
We shall focus on the following age-constant relative
risk model
m (a:e) = [1 + r(e)] m,(a) a > e (2)
and consequently,
m'(a:e) = m(a) + r(e)m,(a)
where r(e) is the excess relative cancer risk for an in-
dividual exposed at age e. It should be emphasized that
this model allows the excess relative risk to depend on
age-at-exposure, but not on age-at-risk. The models
used in the recent analyses of the current follow-up of
the cancer mortality in the LSS cohort are ofthis type,
buttheyalso include alatentperiod(typically 10years).
The modifications needed to deal with a latent period
are described at the end ofthis section. Note also that
risk projections based on Eq. (2) assume that the ex-
posure-induced excess in the form of a constant excess
relative risk continues to the end oflife. This is a very
strongassumption; in the study ofthe long-term effects
of radiation, no exposed human population has been
followed for more than 40 years. The implications of a
leveling-off or a plateau in the excess relative risk for
the excess lifetime risk will be considered in the next
to the last section ofthis paper.
The survivor function, S'(a:e), for a population ofin-
dividuals exposed (and alive) at age e, can now be ob-
tained as
S'(a:e) = S(a:e) exp{-r(e)[M,(a) - M,(e)]}
The second factor represents the additional decrement
ofthe population caused by the excess cancer risk. The
lifetime cancer risk for someone exposed at age e be-
comes
Bc
~~~~~B'(e,r(~e)) = m', (y:e)S'(y:e)dy . (3)
Finally, the excess lifetime cancer risk in a population
exposed at age e is obtained as the difference between
the lifetime risks among exposed and unexposed:
ELR(e,r(e)) = B'(e,r(e)) - B(e) (4)
The excess lifetime cancer risk can be interpreted as
the increase in the proportion of all eventual cancer
deaths in a population of individuals exposed at age e.
It is often presented as the expected number of addi-
tional cancer cases permillion (or thousand) individuals
per unit dose. Appendix A gives some further details
onthe computations necessary to derive the excess life-
time risk.
Let us also briefly introduce two other summary
measuresofthelifelongexcessriskduetotheexposure,
which are occasionallyusedinriskprojections. Thefirst
summary measure is here called the risk of untimely
cancer death, although one may well question the ap-
propriateness ofthis terminology. The risk ofuntimely
cancer death for someone exposed at age e, RUD
(e,r(e)), is defined as a weighted integral ofthe excess
cancer mortality rates with weights given by the back-
ground survivor function
RUD(e,r(e)) = f [m',(y:e) - m,(y)]S(y:e)dy.
In the relative risk model Eq. (2) this simplifies to the
product ofthe excess relative risk and the lifetime risk
from the background cancer
RUD(e,r(e)) = r(e)B(e). (5)
The risk ofuntimely death and the excess lifetime risk
differ on which survivor function is applied to the ex-
posed population. For the former measure the survivor
function used does not include an allowance for the ad-
ditional decrement ofthe population caused by the ex-
cess cancer cases. An interpretation of the risk of un-
timely death may be given by consideringthe following
hypothetical situation. The risk of untimely cancer
deathistheincreaseintheproportionofultimatecancer
deaths if all individuals dying from exposure-induced
cancerarereplacedimmediatelyafterdeathbysomeone
ofthe same age and sex. Note that a given person may
be replaced several times in this hypothetical replace-
ment scheme; this is also reflected in the fact that the
risk ofuntimely death is a linear function ofthe excess
relative risk. Hence values larger than 1 can, in prin-
ciple, occur. As mentioned in the introduction, the risk
ofuntimelydeathhasbeenusedunderthename"excess
lifetime risk" in several publications on risk projections
(3,6,7,9).
The loss of life expectancy for someone exposed at
age e is defined as the difference between the expected
remaining lifetime for an individual exposed at age e
and the expected remaining lifetime if unexposed and
alive at age e. The loss of life expectancy can be cal-
culated as
LLE(e,r(e)) = S(y:e)dy - JS'(y:e)dy. ee (6)
So far we have introduced the excess lifetime risk,
theriskofuntimelydeath, andthelossoflifeexpectancy
for an individual exposed at age e or, equivalently, for
a population of individuals all exposed at age e. The
analogous measures for a population with some distri-
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bution of the age at exposure are simply obtained as a
weighted average of these age-specific measures with
weights proportional tothe age distribution inquestion.
The choice ofage distribution may have a large impact
on the resulting average excess lifetime risk. Risk pro-
jections for the LSS cohort beyond the current follow-
up period are naturally based on the present age dis-
tribution of the survivors, but in other situations the
choice is more arbitrary. The risk projections in the
BEIR III report (7) were based on the 1969-1971 U.S.
life-tables. Age-at-exposure specific excess lifetime
riskswere notgiveninthatreport, butonlytheaverage
value in the so-called life-table population; this is a hy-
pothetical population with the distribution ofage at ex-
posure proportional to the survivor function.
The final problem to be considered in this section is
the impact of a latent period or induction period on the
summary measures introduced above. To this end, as-
sume that the excess cancer mortality does not show
up until t years after the exposure, i.e., the relative
risk model in Eq. (2) is replaced by
m',(a:e) = fm((a) a
< e + t ~[1 +r(e)] m,(a) a > e + t (7)
Straightforward calculations show that in this case, the
excess lifetime risk becomes
S(e + t :e) ELR(e + t,r(e)).
The first term gives the probability of surviving the
latentperiodandthesecond termistheprevious defined
excess lifetime risk [Eq. (4)] for someone alive at age e
+ t when the excess relative risk is r(e).
Similarly, including a latent period of length t leads
to the following risk of untimely death
S(e + t:e) r(e) B(e + t)
and the loss of life expectancy now becomes LLE(e +
t, r(e)).
Results Based on Assuming
Proportional Mortality Rates
Based on a given life-table and the relations derived
in the previous section, it is not too complicated to de-
vise a program that computes the excess lifetime risk
(Appendix A). Whenused, such a program wouldreturn
the appropriate answer, but one would have to consider
a large number ofsituations in order to gain insight into
the relative importance of the various aspects of the
problem. To obtain such insight, an alternative ap-
proach is taken here. It turns out that a simple, explicit
expression for the excess lifetime risk is available if it
is assumed that in the background (unexposed) popu-
lation the cancer mortality rate and the total mortality
rate are proportional as a function of age, i.e.,
m,(a) = B m(a). (8)
This is, of course, not exactly true in any population,
but it will be demonstrated later that the relationship
obtained in this setting is a useful approximation to the
more elaborate life-table calculation. Furthermore, this
approximation provides very important guidance in un-
derstandingthe majorissuesanduncertaintiesinvolved
in computing excess lifetime risks.
The relation in Eq. (8) is equivalent to assuming a
constant proportion of cancer deaths for all ages at
death. Moreover, a simple calculation shows that the
lifetime cancer risk in the unexposed population for
someone alive at age x reduces to independent of the
value of x, i.e.,
B(x) = B. (9)
It is noteworthy that when the ratio ofthe cancer mor-
tality rate to the total mortality rate is constant
throughout life, this constant is also the lifetime cancer
risk. Moreover, this result will be true irrespective of
the particular shape of the overall survivor function.
Turning now to the exposed population, the lifetime
cancer risk [Eq. (4)] can be expressed explicitly as a
function of the (constant) lifetime cancer risk in the
unexposed population and the excess relative risk
B'(e,r(e)) = B [1 + r(e)] / [1 + B r(e)]. (10)
Finally, the excess lifetime cancer risk becomes
ELR(e,r(e)) = r(e) B [1 - B] / [1 + r(e) B]. (11)
Details on the derivation ofrelation between Eqs. (10)
and (11) can be found in Appendix B. The denominator
in Eq. (11) isnegligibly different from 1 forsmall values
ofthe excess relative risk, and indicates, usefully, the
extent to which excess lifetime risks are nonlinear in
r(e) for larger values. The factor [1 - B] reflects the
point made in the introduction that the excess cancer
mortality can only be taken from mortality to other
causes. Note that this simple expression holds for any
shape of the overall survivor function as long as the
proportionality assumption [Eq. (8)] is fulfilled.
The relation in Eq. (11) also reveals, rather surpris-
ingly, that the excess lifetime risk depends on age at
exposure only through the dependence on the excess
relative risk. This means that the excess lifetime risk
would take the same value for all ages at exposure if
the excess relative risk did not depend on e.
Ifalatent period oflength tis present, the expression
in Eq. (11) should be multiplied by the probability
S(e+t:e) ofsurviving the latent period. This will intro-
duce some additional dependence on age at exposure.
However, the comment above on the constancy of the
excess lifetime riskwillthenapplytothe excess lifetime
risk given survival ofthe latent period.
Thedevelopmentsabovesuggestthatforsmallvalues
of the excess relative risk the following approximation
to the excess lifetime risk may be used:
r(e) B[1 - B].
This approximation turns out to be very useful. Forthe
Japanese mortality rates (details later) the approxi-
mation is within about 6 to 7% of the life-table calcu-
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lations for an exposure of0.1 Sv, and the approximation
is even more accurate for an exposure of 1.0 Sv. To
make the approximation less dependent on the addi-
tional assumption in Eq. (8), we allow for the fact that
the lifetime risk, in general, depends on the age of ex-
posure. Thus, for low levels of exposure, the following
approximation to the excess lifetime risk is proposed
r(e) B(e) [1 - B(e)]. (12)
Notethatthisapproximation alsoyields anapproximate
standard error (SE) for the excess lifetime risk. If for
example the excess relative risk r(e) has an 40% SE,
then this will lead to a 40% SE for the excess lifetime
risk (ignoring any uncertainty in the determination of
B(e)).
A comment on the risk of untimely death seems ap-
propriate here. Somewhat surprisingly, a comparison
of relation between Eqs. (5) and (12) shows that the
risk ofuntimely death and the proposed approximation
differ by a factor of 1- B(e) as the excess relative risk
tends to zero. This implies that even for very low ex-
posure levels the risk ofuntimely death for all cancers
except leukemia will be approximately 25% larger than
the corresponding excess lifetime risk.
If a constant latent period of length t is present the
approximation becomes
S(e + t:e) r(e) B(e + t) [1 - B(e + t)]. (13)
Dropping the first factor in Eq. (13) gives an approxi-
mation to the excess lifetime risk given survival of the
latent period.
The performance ofthe approximation in Eq. (12) will
now be studied in the context of estimating the excess
lifetime risk to all cancers except leukemia for individ-
uals receiving an instantaneous exposure to ionizing ra-
diation. The mortality in the unexposed population will
be taken as that ofthe Japanese population in 1965 and
1985 (15-17).
Let usfirst seehowmuchtheJapanese cross-sectional
mortality statistics for the years 1965 and 1985 depart
from the assumption ofproportionality Eq. (8). To this
end it is convenient to reexpress the lifetime risk B(x)
for someone alive at age c as
r0
B(x) = f:(mc(y)/m(y))f(y:x) dy, (14)
where f(y:x) = m(y) S(y:x) is the probability density
function of the lifetime distribution for someone alive
at age x. The ratio mc(y)/m(y) gives the proportion of
cancer deaths amongthose dying at age y, and it is seen
that the lifetime risk is obtained as a weighted average
of these age-specific proportions with weights equal to
the probability of dying for the corresponding age. In
the special case where the cancer mortality rate is pro-
portional to the total mortality rate, this ratio is a con-
stant, B, independent of the age, and as noted earlier,
the lifetime risk then equals this constant.
Figure 1 displays for each sex separately the relative
frequency of nonleukemia cancer deaths among all
deaths in 1965 and 1985, with the age at death grouped
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FIGURE 1. The proportion of nonleukemia cancer deaths among all
deaths with same age at death. Age at death grouped in 5-year
intervals. Calculations are based on Japanese mortality statistics
for 1965 and 1985.
in 5-year intervals. A rather similar pattern is seen:
After an initial rise to a peak in the age group 10 to 14
years ofage, the proportions decline until age 25, then
rise to an overall maximum around age 60 and finally
decrease markedly for the older age groups. For both
sexes the relative frequencies in 1985 are substantially
higher than those in 1965. If leukemia were included
the early peakwould be doubled, but for ages above 40,
only minor changes would be seen. The pattern seen in
Figure 1 may seem far from the constant proportion
predicted by the proportionality assumption in Eq. (8),
but the ages below 55 carry almost no weight when the
lifetime risk is computed as the weighted average in
Eq. (14). Therefore, the lifetime risk B(x) for someone
alive at age x is essentially constant for all values of x
less than 55. This is illustrated in Figure 2 where the
lifetime risk to the nonleukemia cancers for someone
alive at age x is shown as a function ofx for both sexes
based on the Japanese national mortality statistics for
1965 and 1985. Note also the higher values for males in
both years and that the lifetime risk has increased con-
siderably between 1965 and 1985.
In connection with Figures 1 and 2 it should be noted
that a recent investigation of the LSS autopsy data
(Jablon, private communication) has shown that the de-
tection rate of cancer as the cause of death as deter-
mined death certificates decreases markedly at older
ages; this is true for specific sites and for all cancers
except leukemia together. Thus, the drop-off seen in
Figures 1 and 2 for old ages may, in part, be the con-
sequence of such a decrease in the detection rate; the
true rates may actually comply better with the as-
sumptions of the approximation.
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The behavior of the approximation over a range of
excess relative risk values is displayed in Figure 4.
Weighted averages ofthe age-at-exposure-specific val-
ues of the proposed approximation and the life-table
calculation were computed by applying the age distri-
>.0 o; butionofthe life-tablepopulationtothe ageat exposure.
--4--4 s s Figure 4 gives the ratio ofthese weighted averages as
a function ofthe excess relative riskforeach sex in 1965
and 1985. It is seen that the approximation stays within
± 7% of the life-table calculation for excess relative
risks smaller than 0.8. However, by far, the most re-
markable feature of this figure is the almost-perfect
linearity of the ratio of the approximation to the life-
table-based value when plotted against the excess rel-
60 8 s ative risk. Note that this ratio would be exactly linear
80 90 ifthe proportionality assumption [Eq.(8)] was satisfied
[Eq. (11)]. This pattern suggests that an extremely ac-
imation to the excess curate approximation to the excess lifetime risk will
alue to the exact value have the form
;s relative risk of0.05.
The performance of the proposed approximation for
the excess lifetime risk when applied to radiation-in-
duced nonleukemia cancers is shown in Figures 3 and
4. The dependence on the age at exposure for a fixed
value ofthe excess relative risk is considered in Figure
3. Here the ratio of the approximate value from Eq.
(12) to the exact value obtained from Eq. (4) using the
life-table method is plotted against age-at-exposure for
each sex in 1965 and 1985. The value 0.05 has been
chosen for the excess relative risk. This corresponds
roughly to the estimated average excess riskinthe LSS
cohort for a dose of0.1 Sv. The values shown are those
obtained when no latent period is present, but the in-
troduction of a latent period will only result in a trans-
lation of the age scale. The relation in Eq. (12) is seen
r(e) B(e) [1 - B(e)] / [a + b r(e)].
It is actually possible, quite generally, to devise a re-
fined approximation of this form, but this will not be
pursued further, since the emphasis here is on simple
and easily interpretable approximate relations. More-
over, such improved approximations offer no compu-
tational advantages relative to the life-table method.
Approximation under Weaker
Assumptions
In this section results are given for the age-constant
relativeriskmodel [Eq. (2)], butwithouttheassumption
in Eq. (8) that cancer and total mortality rates are pro-
portional. In this general setting no explicit expression
for the excess lifetime risk similar to Eq. (11) is avail-
x
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able. However, an approximate expression can still be
obtained. Write B(e) as the average ofthe background
lifetime riskB(e) with respect to the distribution ofage
at cancer death where all these quantities are condi-
tional on being alive at age e. That is,
( B(y)f,(y:e) dy
B(e)= X
JfL(y:e) dy
where
f,(y:e) = mj(y) S(y:e)
is the density oftime to cancer death for those alive at
age e.
Then for small r(e) an approximation without relying
on assumption in Eq. (8) is
r(e) B(e)[1 - B(e)]. (15)
This and the following results are developed in Appen-
dix C. In fact, the approximation in Eq. (15) is anupper
bound for the excess lifetime risk, and moreover it is
shown that the ratio of Eq. (15) to the exact value is
bounded between 1 - r(e)B(e)/[1 - B(e)] and 1. Thus
Eq. (15) is a very good approximation for the values of
r(e) in the range ofinterest. A modification to deal with
the latent period can easily be devised along the lines
given at the end ofthe second section.
It is emphasized that the approximation in Eq. (15)
is based on the age-constant relative risk model (but is
otherwise general). For small values ofthe excess rel-
ative risk, it is negligibly different fromresults ofexact
life-table calculations. Actual use ofthe approximation
is of little value, however, since calculation of B(e) is
essentially as difficult as the life-table calculation. The
point of this more general approximation is to better
understand the error in approximation in Eq. (12) and
the one preceding it.
It is seen that the general result in Eq. (15) is very
similar to the proposed approximation in Eq. (12), and
unlessthe lifetimecancerriskvariesmarkedlywithage,
especially on the range of ages where cancer deaths
typically occur, the last factor in Eq. (15) will be close
to 1 - B(e) for the age at exposure in this age span.
Thus, for small values of the excess relative risk r(e),
the ratio of the approximate expression in Eq. (12) to
the exact life-table calculation is essentially equal to [1
- B(e)]/[1 - B(e)]. Moreover, this ratio will tend to be
smaller than one if most of the cancer deaths occur in
the age groups where cancer is becoming a less impor-
tant cause of death. When the ratio [1 - B(e)]/[1 -
B(e)] is slightly smallerthanone, theapproximation will
underestimate the excess lifetime risk for r(e)-values
close to zero, but this may actually increase the range
ofr(e)-values for which an acceptable approximation is
obtained (Fig. 4).
In conclusion, the existence of a general approxima-
tion of the form in Eq. (15) clearly indicates that the
simple expression in Eq. (12) is a useful approximation
to the excess lifetime risk for low exposure levels, not
only when the cancer and total mortality rates are pro-
portional.
Several Exposure-Related Causes of
Deaths
In the basic competing risk model introduced in the
second section, the cause of death information is ag-
gregated into two main causes: those related to expo-
sure, called cancer; and those unrelated to exposure,
called noncancer. Inthe majorreviews ofthe long-term
effects ofionizingradiation (6,7)much attention isgiven
to estimating lifetime risks of dying from radiation-in-
duced cancers of specific sites. There are additional
problems arising in such an endeavor.
First it must be realized that site-specific excess life-
time risk calculations depend on whether one is consid-
ering site-specific exposure or whole-body exposure.
This is particularly important ifone expects the sum of
the site-specific excess lifetime risks to represent the
excess lifetime risk for a collection of sites in whole-
body exposure. Technically speaking, incalculations for
a given site the problem is whether or not the survivor
function of S'(a:e) is decremented for the excess mor-
talityrateofotherradiogeniccancers. Eitherpossibility
is correct but relates to different situations: for site-
specific exposure the additional decrement is not ap-
propriate, whereas for whole-body exposure it is re-
quired.
It is convenient to base the arguments on the ap-
proximate relationship forthe excess lifetime riskwhen
tryingto quantify the orderofmagnitude ofthese prob-
lems. Moreover, for the points to be made here it is
necessary to expand the competing risks model to in-
clude three causes of death, two of which are related
to exposure. To fix the terminology we shall refer to
these two causes as "lung cancer" and "other cancers,"
with the understanding that the results are not re-
stricted to this particular subdivision ofall cancers. For
both of these causes the effect of exposure will be de-
scribed by an age-constant relative risk model of the
form in Eq. (2).
Among unexposed let B1 and B2 denote the lifetime
risksoflungcancerandothercancers, respectively. The
corresponding excess relative risks are denoted r, and
r2. The B's and the rs will depend on age at exposure,
butthisdependence hasbeensuppressedinthenotation
since it is not central to the developments here.
For site-specific exposure the excess lifetime risk of
death to lung cancer is approximately
r, B1 [1 - B1].
This follows directly from the results in the second and
third sections since deaths to other cancers and non-
cancer deaths may be pooled together as causes unre-
lated to the site-specific exposure. For whole-body ex-
posure calculations similar to those given in Appendix
B lead to the following approximate excess lifetime risk
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r, B2 [1 - BJ] - r2B1 B2, (16)
showing that for a given site the excess lifetime risk is,
in general, smaller for whole-body exposure. The sum
of a number of site-specific excess lifetime risks each
based on site-specific exposure will therefore be larger
than the excess lifetime risk for the collection of sites
in whole-body exposure. Note also that the excess life-
time risk in Eq. (16) may in certain situations become
negative even though the excess relative risk r1 is pos-
itive. This will happen ifthe excess relative risk r2 as-
sociated with other cancers is larger than r1 [1 - B1]!
B2. The relation in Eq. (16) may alternatively be ex-
pressed as
r1B1 [1 - B1 - B2] + (r1 - r2) B1 B2. (17)
Excess relative risk estimates are very similar formost
solid tumors indicating that the second term in Eq. (17)
typically contributes little, if anything, to the excess
lifetime risk. Thus, the important difference between
the excess lifetime risk from site-specific exposure and
that from whole-body exposure shows up in the factor
oneminusthebackground lifetimeriskfortheradiation-
related causes of death. For site-specific exposure this
is 1 - B1, and for whole-body exposure it becomes 1
- (B1 + B2).
Summing Eq. (17) and the corresponding (approxi-
mate) expression for the excess lifetime risk to death
from other cancers gives the excess lifetime risk to all
cancers from whole-body exposure
[r1 B1 + r2B2][1 - B1 - B2]. (18)
Introducing the total background lifetime cancer riskB
- B1 + B2, this may be written as
r B [1 - B]
where
r = [r1 B1 + r2B2] l [B1 + B2] (19)
is aweighted average ofthe site-specific excess relative
risks with weights proportional to the site-specific life-
time risks. Thus, the expression in Eq. (18) is formally
identicaltotheapproximaterelationderivedinthethird
section. The weightingin Eq. (19) is equivalent tousing
weights proportional to the number ofdeaths from the
different causes in the background population. An ex-
cess relative risk analysis of the mortality data for a
collection of cancer sites by maximum likelihood meth-
ods implicitly uses a similar weighting ofthe data from
the individual sites, indicatingtheresults obtained from
separate site-specific calculations willbeconsistent with
those found when analyzing the collection of sites to-
gether. There are some complications here that should
berecognized: thevalidityofexcessrelative riskmodels
for the individual sites does not, in general, ensure that
an excess relative risk model will be appropriate when
the sites are aggregated into a single cause of death
(e.g., all cancers). If cancers occurring late in life gen-
erally have a smaller excess relative risk, one would
expect to find an excess relative risk decreasing with
follow-up time for all cancers together. It is not clear
towhatextent this willinvalidate the consistencyresult
outlined above.
Some Further Issues
For radiation-induced cancers, no epidemiological
studyexistsinwhichthe entire cohorthasbeenfollowed
until all members have died. Therefore, risk projection
methods giving a summary oflifelong excess risk inev-
itably involve some sort of extrapolation of effects in
time and age beyond our current knowledge. In a dis-
cussion ofthe uncertainties involved in such projections
it is necessary to distinguish between two types of ap-
plications: determination ofthe ultimate number ofex-
cess cancer cases (or lifetime risk) in a specific study
cohort of exposed individuals, and computation of the
excess lifetime risk in some theoretical population as-
sumed exposed to a single dose ofradiation.
Theformersituationisconvenientlydiscussedbycon-
sidering the LSS cohort. Here the excess number of
cancer cases in the first 40 years offollow-up is mainly
aquestionoffindingsuitablemodelstodescribeexisting
data, so the extrapolation concerns only those below 45
to 50 years of age at exposure. The extrapolation in-
volves both the future background cancermortality and
the future excess relative cancer risk. As shown in the
section "Results Based on Assuming Proportional Mor-
tality Rates," the background cancermortality inJapan
hasincreasedsubstantiallyfrom 1965to 1985, indicating
that this aspect ofthe extrapolation will require a mod-
eling of the time trend in the background mortality
rates.
In the latter type of application one will usually as-
sume that the total mortality and the cancer mortality
are as specified by some life-table, and extrapolation of
this background mortality is handled by assuming that
theseratesprevailforthewholelifespan. Extrapolation
ofthe excess relative riskforthose under45to 50 years
of age at the time of exposure remains and important
issue. Moreover, the relevance of applying the excess
relative risks found in the LSS cohort to the population
inquestion needs also to be considered, especiallyifthis
population has a very different pattern of cancer mor-
tality. Instead of transferring the excess relative risk
estimates, one may contemplate computing the (time-
and age-dependent) absolute excess risk in the LSS co-
hort and add this excess to the background cancer rate
of the population life-table. An approach of this type
was adopted by the BEIR III committee in their cal-
culations (7).
The lack of knowledge about the future behavior of
the excess relative risk for those exposed as young is
the source of considerable uncertainty in both types of
risk projections. This is illustrated in Table 1, where
the implications onthe excess lifetime nonleukemia can-
cer risk ofthree different models forthe duration ofthe
excess risk are compared. The results are given forfour
different values of age at exposure for both males and
females. Calculations are based on the 1985 Japanese
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Table 1. Excess lifetime nonleukemia cancer risks from a
radiation exposure of 0.1 Sv for different choices of length of
the plateau in the excess relative risk.a
Males
Age at exposure, yr
15 30 45 60
ERR at 0.1 Sv 0.075 0.050 0.025 0.025
Lifetime risk 0.238 0.241 0.242 0.231
ELR infinite plateau 0.015 0.010 0.005 0.004
ELR 40-yr plateau 0.003 0.007 0.005 0.004
ELR 30-yr plateau 0.001 0.004 0.004 0.004
Females
ERR at 0.1 Sv 0.150 0.100 0.050 0.050
Lifetime risk 0.162 0.162 0.159 0.147
ELR infinite plateau 0.021 0.014 0.007 0.005
ELR 40-yr plateau 0.005 0.009 0.007 0.005
ELR 30-yr plateau 0.002 0.004 0.006 0.005
aCalculations are based on the 1985Japanese life-table and alatent
period of 10 years is assumed.
life-table, and allmodelsinclude a 10-yearlatent period.
The first model assumes a lifelong excess relative risk,
whereas the second and third models have a plateau in
the excess risk lasting for 40 years and 30 years, re-
spectively. The excess relative risk estimates are es-
sentially those given by Pierce et al. (18) for all cancers
except leukemia. These estimates are obtained by fit-
ting an age-constant excess relative risk model linear
dose. The dose was taken as the DS86 dose to the large
intestine using a low-LET dose equivalent based on an
assumed relative biological effectiveness (RBE) of 10
for neutrons. A 10-year latent period is assumed. Their
estimation procedure allows for random errors in the
dose estimates, and the analysis is based on follow-up
until the end of 1985. The slope of the dose response
depends on sex and age at exposure, the latter factor
being categorized as 0 to 19, 20 to 34, and 35 and older.
The SE of estimated excess relative risks is approxi-
mately 40%.
Table 1 summarizes the consequences of a single ra-
diation exposure of0.1 Sv. Sincethe excessrelativerisk
estimates are based on a linear dose-response model,
one might consider a further adjustment to allow for a
possible nonlinearity of the dose response in the low-
dose range. This has not been attempted here, but it
may well lead to a reduction ofthe excess relative risk
by 30 to 50% (19). Also, the BEIR III committee (7)
used a correction factor of 1.23 to adjust for incomplete
death-certificate ascertainment of cancer as the cause
of death.
The results in Table 1 clearly indicate the major un-
certainty in the risk projection for those exposed as
children or young adults. The first and the third model
probably represent two extreme modes ofextrapolation
and the results differ by more than a factor 10 forthose
exposed at ages below 20. Thelarge excess relative risk
foundinthisgroupinthe currentfollow-up should never
be used uncritically in risk projections. At best, very
strong (and untestable) assumptions are required to
make any useful estimates from LSS regarding lifetime
risksforthisgroup. Viewedinthisperspectivethemod-
est underestimation resulting from the approximation
proposed in the third section is, indeed, a minor issue.
As a crude approximation to the effect on the excess
lifetime cancer risk of a plateau in the excess relative
risk one may use the following simple rule: multiply the
excess lifetime risk obtained for lifelong excess risk by
theprobabilityofdyingduringtheperiodwithincreased
risk given survival ofthe latent period.
Finally, letusbriefly considerprojections ofriskfrom
continuous exposure. The calculation ofexcess lifetime
risks in this setting is potentially much more compli-
cated. First ofall, there is an additional parameter, the
dose rate, to take into account. Moreover, the problem
of how to model the dependence ofthe age-specific ex-
cess relative risk on the previous exposure history is
not an easy one. Here, we shall restrict ourselves to
the simplest possible situation, that ofan exposurewith
a constant dose rate d starting at age e and continuing
throughout the rest of life. Furthermore, it will be as-
sumed that the excess relative risk is linear in the cu-
mulative dose, such that the excess relative risk at age
abecomes b(e)d(a - e), where b(e)isthe excessrelative
risk per unit (cumulative) dose. Under these circum-
stances (and foralowdose rate) one mayconsiderusing
b(e) d MRL(e) B(e) [1 - B(e)]
as an approximation to the excess lifetime risk associ-
ated with the exposure. Here MRL(e) is the mean re-
maining lifetime for someone alive at age e. Under the
further assumption of proportional mortality rates in
Eq. (8), one may show that this relation gives an upper
bound for the excess lifetime risk. An empirical inves-
tigation, similar to those reported in the third section
but on a much smaller scale, gave the following results
for nonleukemia cancer: for age-at-exposure below 80
yearstheratiooftheapproximationtothevaluederived
from a life-table calculation varied between 1.01 and
1.23 for males in 1985 and between 1.05 and 1.25 for
females in 1985. The corresponding values based on the
1965 life-table were 1.00 to 1.23 for males and 1.06 to
1.33 for females. These values are all derived in a sit-
uation with no latent period, and the excess relative
risk per year b(e) x d was 0.005 Sv. This corresponds
roughly to a dose rate of 0.01 Sv/year, assuming that
the average excessrelative riskfoundinthe LSScohort
at this dose level can be applied in the present setting.
The approximation is obviously less satisfactory than
those obtained for a single exposure, but it may still be
useful when assessing the order of magnitude of the
excess lifetime risk from continuous exposure at low-
dose rates.
Concluding Remarks
In an area like lifetime risk projections that clearly
involves speculations about events yet to occur, it is
critical to make the structure of the relationships as
clear as possible. It is felt that an approach using the
simple approximation described in this paper is a useful
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alternative to the less-transparent life-table calcula-
tions. This approximation is based on an age-constant
excess-relative risk model. By now, the only serious
doubt about the appropriateness of this type of model
for the cancer mortality in the LSS cohort is for those
who were exposed as children and young adults. The
uncertainty in the risk projection for this group, espe-
cially for the children, is extremely large, though, and
any serious assessment of excess lifetime risks should
address this problem. The most appropriate approach
here seems to be to investigate the sensitivity of the
excess lifetime risk to various models for the future
magnitude and duration ofthe excess mortality in this
group. Some preliminary calculations along these lines
are presented in Table 1; more realistic models will
probably involve a gradually leveling off of the excess
relative risk.
Appendix A
This appendix describes how the lifetime risk and the
excess lifetime risk are derived from alife-table and the
corresponding cancer mortality statistics. Such infor-
mation is always provided for each sex separately, but
to simplify the discussion this distinction will be made
explicit here.
A life-table for a given population for a given period
describes how a hypothetical cohort of 100,000 newly
bornindividuals is diminished bynormalmortality from
all causes under the assumption that the age-specific
mortalityisidenticaltothatfoundinthetotalpopulation
in the period. The life-table gives the number of indi-
viduals still alive at each subsequent birthday (i.e., at
age 1, 2, 3, etc.) until the whole cohort has died. Cause-
specific mortality statistics are usually given as the
cause-specific mortality rate for 5-yearage groups (i.e.,
0-4, 5-9, etc.).
To obtain the lifetime cancer risk for someone unex-
posed and alive at age e from Eq. (1) using this infor-
mation, one may proceed as follows: the integral on the
right hand side of Eq. (1) is written as the sum of the
integral from age e to age e + 1, the integral from age
e+ 1 to e + 2, the integral from age e + 2 to e + 3,
etc. Each of these integrals is then computed as the
cancer mortality rate for the age in question times the
average cohort size at that age divided by the size of
the cohort at age e. The lifetime cancer risk is then
obtained as the sum ofthese expressions.
The lifetime cancer risk for some exposed at age e is
derived in a similar way from Eq. (3). The cancer mor-
tality rate is here 1 + r(e) times that ofthe background
population [Eq. (2)]. The values ofthe survivorfunction
S'(a:e) are obtained recursively for a = e, e + 1, e +
2,... from the relation
S'(a + 1:e) = S'(a:e) S(a + l:a) exp{-r(e)m,(a)},
where S'(e:e) = 1 and S(a + l:a) is the ratio ofthe life-
table cohort size at age a + 1 to that at age a. The
lifetime cancer risk for someone exposed at age e given
in Eq. (3) may now be evaluated as a sum ofthe terms
(1 + r(e)) m,(a) [S'(a + 1:e) + S'(a:e)]/2
for a = e, e + 1, e + 29.... Finally, the excess lifetime
cancer risk is found as the difference between the life-
time risk for the exposed and the lifetime risk for the
unexposed [Eq. (4)].
Appendix B
Derivation of relation Eqs. (10) and (11): From Eq.
(3) we have
B'(e,r(e)) = f m'c(y:e) S'(y:e) dy.
For the age-constant relative risk model this becomes
00
B'(e,r(e)) = f(1 + r(e))mm(y) expf-[M(y)
- M(e)] - r(e)[M,(y) - M,(e)]} dy.
If the additional assumption in Eq. (8) is fulfilled, we
get
= f(1 + r(e)) B m(y)
exp{-1 + r(e)]B[M(y) - M(e)]}dy
- (1+rr(e))B I(1 + r(e)B) m(y)
exp{-[1 + r(e)B][M(y) - M(e)]} dy
(1 + r(e))B
1 + r(e) B'
since the integral equals one. The relation in Eq. (11)
is finally obtained by subtracting offB.
Appendix C
The following result is shown in this appendix: for an
age-constant relative riskmodelthe excess lifetime risk
ELR (e,r(e)) is always smaller than
r(e) B(e) [1 - B(e)]
and always larger than
r(e) B(e) [1 - B(e)] - B(e) B(e) r(e)2,
where B(e) is the lifetime risk averaged over the dis-
tribution ofage at cancer death among unexposed alive
at age e. Note thatthe simple approximationin Eq. (10)
doesnotnecessarilystaywithinthesebounds. Notealso
thatthe ratio ofthese bounds tends to one as the excess
relative risk approaches zero. This implies that the
bounds areverytightforexposurelevelsleadingtoonly
small excess relative risks.
Aproofofthisresultisheregivenforage at exposure
e = 0. The prooffor general e is quite similar. To sim-
plifythe notation letrdenote the excessrelative cancer
risk if exposed at age 0.
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To find the lower bound for the excess lifetime risk
a lower bound for the lifetime risk in the exposed pop-
ulation is first established
B'(O,r) = [1 + r] fmc(y) S(y) exp{-rM,(y)} dy
= [1 + r] G(r),
where G(r)isdefined astheintegralabove. Thefunction
G(r) is adecreasing, convex function (it is actually com-
pletely monotone) taking the value B(O) for r = 0.
Therefore,
B(O) + r DG(O)
- G(r)
and
[1 + r][B(O) + DG(O)] < B'(O,r), (Cl)
where DG denotes the first derivative ofG. It remains
to find an expression for DG(O). Now
x0 Y
DG(O) = - f m"(y) S(y) f m,(x) dx dy.
y=O X=O
Interchanging the order ofintegration leads to
= - f mM(x) S(x) f mc(y) S(y:x) dx dy
x=O y=x
00
= - fmc(x) S(x) B(x) dx
0
= - B(O) B(O),
where B(O) is the mean value of the lifetime risk B(x)
in the distribution oftime to cancerdeaths amongthose
eventually dying from (background) cancer.
The lower bound for the excess lifetime cancer risk
is now obtained by insertingthis expression in Eq. (Cl)
and subtracting offthe lifetime risk among unexposed.
To derive the upperbound, firstnotethatthelifetime
cancer risk is one minus the lifetime noncancer risk.
Thus
B'(0,r) = 1 - fmn(Y) S(y) exp{-rMj(y)} dy
= 1 - H(r),
whereH(r)isthedefined astheintegralinthepreceding
line. The functionH(r) is also adecreasing, convex func-
tion and takes the value 1 - B(O) for r = 0, so
1 - B(O) + r DH(O) < H(r)
and
B'(O,r)
- B(O) - r DH(O), (C2)
where DH denotes the first derivative ofH. Now
xc Y
DH(O) = - f mn(y) S(y) f mc(x) dx dy.
y=O x=O
After interchanging the order ofintegration and some
further manipulations simnilar to those above
= - fO rn(x) S(x)[1 - B(x)] dx
= - B(O) [1 - B(O)].
Inserting this in Eq. (C2) and subtracting offB(O) gives
the desired upper bound for the excess lifetime risk.
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